Antidepressive Agents, Second-Generation
"Antidepressive Agents, Second-Generation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake.
MeSH Number(s)
D27.505.954.427.700.122.050
Concept/Terms
Antidepressive Agents, Second-Generation- Antidepressive Agents, Second-Generation
- Antidepressive Agents, Second Generation
- Antidepressive Drugs, Second-Generation
- Antidepressive Drugs, Second Generation
- Drugs, Second-Generation Antidepressive
- Second-Generation Antidepressive Drugs
- Atypical Antidepressants
- Second-Generation Antidepressive Agents
- Agents, Second-Generation Antidepressive
- Second Generation Antidepressive Agents
- Antidepressants, Atypical
Below are MeSH descriptors whose meaning is more general than "Antidepressive Agents, Second-Generation".
Below are MeSH descriptors whose meaning is more specific than "Antidepressive Agents, Second-Generation".
This graph shows the total number of publications written about "Antidepressive Agents, Second-Generation" by people in Harvard Catalyst Profiles by year, and whether "Antidepressive Agents, Second-Generation" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 1 | 0 | 1 |
| 1996 | 10 | 2 | 12 |
| 1997 | 8 | 4 | 12 |
| 1998 | 7 | 4 | 11 |
| 1999 | 5 | 2 | 7 |
| 2000 | 4 | 4 | 8 |
| 2001 | 7 | 3 | 10 |
| 2002 | 11 | 4 | 15 |
| 2003 | 10 | 1 | 11 |
| 2004 | 14 | 7 | 21 |
| 2005 | 12 | 3 | 15 |
| 2006 | 8 | 6 | 14 |
| 2007 | 12 | 5 | 17 |
| 2008 | 8 | 3 | 11 |
| 2009 | 15 | 4 | 19 |
| 2010 | 12 | 3 | 15 |
| 2011 | 3 | 4 | 7 |
| 2012 | 8 | 3 | 11 |
| 2013 | 11 | 3 | 14 |
| 2014 | 7 | 1 | 8 |
| 2015 | 5 | 4 | 9 |
| 2016 | 4 | 3 | 7 |
| 2017 | 4 | 1 | 5 |
| 2018 | 3 | 1 | 4 |
| 2019 | 5 | 1 | 6 |
| 2020 | 0 | 2 | 2 |
| 2021 | 3 | 2 | 5 |
Below are the most recent publications written about "Antidepressive Agents, Second-Generation" by people in Profiles.
-
Efficacy of Fluoxetine for Post-Ischemic Stroke Depression in Tanzania. J Stroke Cerebrovasc Dis. 2022 Jan; 31(1):106181.
-
Chasing the Offending Medication: When Antidepressants Lead to Hypoglycemia. J Clin Psychopharmacol. 2021 Nov-Dec 01; 41(6):698-699.
-
Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness Scores into Clinical Global Impressions Clinical Significance Levels in Four Randomized Clinical Trials of SPN-812 (Viloxazine Extended-Release) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2021 04; 31(3):214-226.
-
Molecular imaging of beta-amyloid deposition in late-life depression. Neurobiol Aging. 2021 05; 101:85-93.
-
Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD): A Randomized, Double-Blind, Placebo-Controlled Trial. J Clin Psychiatry. 2021 01 12; 82(1).
-
Bupropion associated seizures following acute overdose: who develops late seizures. Clin Toxicol (Phila). 2020 12; 58(12):1306-1312.
-
Effective Pharmacogenomic-driven Treatment of Major Depression: A Case Report. Psychiatr Danub. 2020; 32(3-4):428-430.
-
Implementation research for public sector mental health care scale-up (SMART-DAPPER): a sequential multiple, assignment randomized trial (SMART) of non-specialist-delivered psychotherapy and/or medication for major depressive disorder and posttraumatic stress disorder (DAPPER) integrated with outpatient care clinics at a county hospital in Kenya. BMC Psychiatry. 2019 12 28; 19(1):424.
-
Latent Profiles of Cognitive and Interpersonal Risk Factors for Adolescent Depression and Implications for Personalized Treatment. J Abnorm Child Psychol. 2019 12; 47(12):1957-1967.
-
Pediatric Bupropion Ingestions in Adolescents vs. Younger Children-a Tale of Two Populations. J Med Toxicol. 2020 01; 16(1):6-11.